Meghatározott bútor irányítószám antibodies to markers such as abeta mild cognitive impairment alzheimer távcső örök szemét
The Amyloid-β Pathway in Alzheimer's Disease | Molecular Psychiatry
Physiological Roles of Monomeric Amyloid-β and Implications for Alzheimer's Disease Therapeutics
Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review - ScienceDirect
SARS-CoV-2 infection increases the gene expression profile for Alzheimer's disease risk: Molecular Therapy - Methods & Clinical Development
Nasal administration of anti-CD3 monoclonal antibody ameliorates disease in a mouse model of Alzheimer's disease | PNAS
Structural Dynamics of Amyloid-β Protofibrils and Actions of Anti-Amyloid-β Antibodies as Observed by High-Speed Atomic Force Microscopy | Nano Letters
Amyloid blood biomarker detects Alzheimer's disease | EMBO Molecular Medicine
Isoorientin Affects Markers of Alzheimer's Disease via Effects on the Oral and Gut Microbiota in APP/PS1 Mice - The Journal of Nutrition
Pyroglutamate Aβ cascade as drug target in Alzheimer's disease | Molecular Psychiatry
Amyloid β-based therapy for Alzheimer's disease: challenges, successes and future | Signal Transduction and Targeted Therapy
Amyloid‐β oligomers in cellular models of Alzheimer's disease - Fontana - 2020 - Journal of Neurochemistry - Wiley Online Library
Blood‐based biomarkers for Alzheimer's disease | EMBO Molecular Medicine
Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer's disease in individuals with subjective cognitive decline | Alzheimer's Research & Therapy | Full Text
Pro-inflammatory interleukin-6 signaling links cognitive impairments and peripheral metabolic alterations in Alzheimer's disease | Translational Psychiatry
IJMS | Free Full-Text | Potential Fluid Biomarkers for the Diagnosis of Mild Cognitive Impairment
JPM | Free Full-Text | Current Biomarkers for Alzheimer's Disease: From CSF to Blood
Frontiers | Manipulation of the diet–microbiota–brain axis in Alzheimer's disease
An App knock-in rat model for Alzheimer's disease exhibiting Aβ and tau pathologies, neuronal death and cognitive impairments | Cell Research
Identifying and validating biomarkers for Alzheimer's disease: Trends in Biotechnology
Amyloid-β (Aβ) marker expression and Aβ aggregation in the... | Download Scientific Diagram
Association of B cell profile and receptor repertoire with the progression of Alzheimer's disease - ScienceDirect
Frontiers | Bridging the Gap Between Fluid Biomarkers for Alzheimer's Disease, Model Systems, and Patients
Advances in the development of new biomarkers for Alzheimer's disease | Translational Neurodegeneration | Full Text
IJMS | Free Full-Text | CSF Biomarkers in the Early Diagnosis of Mild Cognitive Impairment and Alzheimer’s Disease
Fc effector of anti-Aβ antibody induces synapse loss and cognitive deficits in Alzheimer's disease-like mouse model | Signal Transduction and Targeted Therapy
Biomolecules | Free Full-Text | Microvascular Contributions to Alzheimer Disease Pathogenesis: Is Alzheimer Disease Primarily an Endotheliopathy?
Decreased salivary lactoferrin levels are specific to Alzheimer's disease - eBioMedicine